MedTrace Logo

Non-Invasive Measurement of SjvO2 Using Near Infrared Spectroscopy in Critically Ill Patients

NCT04624009 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2023-11-29

No results posted yet for this study

Summary

ScvO2 is an important parameter in the management of critically ill patient. The only way to measure it is to have an internal jugular or subclavian central venous catheter. With this trial, the investigators want to show a positive relationship between invasive ScvO2 measurement and noninvasive SjvO2 measurement with VO 100 medical device from Mespere LifeSciences, allowing the use of SjvO2 as a noninvasive surrogate of ScvO2 in critically ill patients.

Conditions

  • Impaired Oxygen Delivery
  • Critically Ill Patient

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-04-01
Completion
2023-08-01

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04624009 on ClinicalTrials.gov